Login / Signup

A Case of Thrombocytosis Associated with Enoxaparin Therapy in an Adolescent.

Robert MurrayJoseph Drew Tobias
Published in: Clinical pharmacology : advances and applications (2021)
Secondary thrombocytosis, often referred to as a reactive thrombocytosis, is more common than primary thrombocytosis and has many potential etiologies including anemia, infection, inflammation, medications, and post-splenectomy. When considering the critically ill patient in the ICU setting potential medication-related etiologies of thrombocytosis should be included in the differential diagnosis. We present a 15-year-old adolescent with a traumatic brain injury who developed thrombocytosis that was temporally related to the administration of enoxaparin. There was a prompt return of the platelet count to normal following the discontinuation of enoxaparin therapy which led to the probable diagnosis of enoxaparin-induced thrombocytosis.
Keyphrases
  • venous thromboembolism
  • traumatic brain injury
  • young adults
  • mental health
  • healthcare
  • stem cells
  • drug induced
  • mechanical ventilation
  • adverse drug
  • severe traumatic brain injury